Clinical Trial Update: TGRX-678 Pharmacokinetic Mass Balance [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic mass balance study of TGRX-678 has been completed, summarizing absorption, distribution, metabolism, and excretion characteristics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• TGRX-678

Snippet

Sponsor: Shenzhen TargetRx Co., Ltd. | Conditions: Chronic Myeloid Leukemia | Phase 1 | Status: COMPLETED